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embrane trafﬁc between the endoplasmic reticulum
 
(ER) and Golgi apparatus and through the Golgi
apparatus is a highly regulated process controlled
by members of the rab GTPase family. The GTP form of
rab1 regulates ER to Golgi transport by interaction with the
vesicle tethering factor p115 and the cis-Golgi matrix
protein GM130, also part of a complex with GRASP65
important for the organization of cis-Golgi cisternae. Here,
M
 
we ﬁnd that a novel coiled-coil protein golgin-45 interacts
with the medial-Golgi matrix protein GRASP55 and the GTP
form of rab2 but not other Golgi rab proteins. Depletion of
golgin-45 disrupts the Golgi apparatus and causes a block in
secretory protein transport. These results demonstrate that
GRASP55 and golgin-45 form a rab2 effector complex on
medial-Golgi essential for normal protein transport and
Golgi structure.
 
Introduction
 
The mammalian Golgi apparatus is composed of an ordered
 
stack of cisternae often found in the perinuclear region of
mammalian cells (Farquhar and Palade, 1998). This stacked
 
cisternal structure is established by the action of a peripheral
Golgi matrix or exoskeleton (Slusarewicz et al., 1994;
Seemann et al., 2000a). The best characterized of these
Golgi matrix proteins are the vesicle tethering protein p115,
GM130, the integral membrane protein giantin, and the
two GRASP proteins GRASP55 and GRASP65 (Linstedt
and Hauri, 1993; Nakamura et al., 1995; Barr et al., 1997;
Nakamura et al., 1997; Shorter et al., 1999; Allan et al.,
2000). These factors have been shown to be important for
the establishment of properly ordered cisternae in a cell-free
assay, recreating the reassembly of the Golgi apparatus after
mitosis (Rabouille et al., 1995; Barr et al., 1997; Nakamura
et al., 1997; Shorter and Warren, 1999; Shorter et al., 1999;
Lesa et al., 2000). How the stacking of cis-Golgi cisternae is
promoted by the p115-GM130-GRASP65 complex and
giantin is unclear; we favor a model whereby cisternae arise
by vesicle docking and fusion, but at some point cisternal
fusion is prevented, allowing Golgi stack formation (Barr et
al., 1997; Shorter and Warren, 1999). This process may be
regulated by the Golgi-associated rab GTPases, since rab1
associates with p115 and GM130 (Allan et al., 2000; Moyer
et al., 2001; Weide et al., 2001), and nonhydrolyzable GTP
analogs promote the stacking of Golgi cisternae in vitro,
although having no effect on membrane fusion (Rabouille et
al., 1995).
Studies to date have almost entirely addressed Golgi
matrix proteins present on the cis-Golgi, and it is unclear
what mechanism would operate at other levels of the Golgi
stack. Previously, we identified GRASP55 on the medial-Golgi
as a factor important for the formation of Golgi stacks in
vitro (Shorter et al., 1999). Therefore, we set out to identify
and characterize proteins present in complexes with both
GRASP55 and Golgi rab GTPases and to address the function
of these complexes in vivo.
 
Results and discussion
 
We adopted a two-pronged approach to identify
GRASP55-interacting proteins: comparing proteins identified
using the yeast two-hybrid system and biochemical isolation
of GRASP55 complexes from Golgi membranes. First, a
cDNA library was screened with GRASP55 as the bait, and
several clones were identified corresponding to the Golgi
matrix protein GM130 and a ubiquitously expressed 45-kD
protein described previously as a potential transcription factor
(Tong et al., 1998). For reasons outlined below, we refer to
this protein as golgin-45 (Fig. 1 A). The presence of
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GM130 was expected, since it is known to interact with
GRASP55 in the yeast two-hybrid system (Shorter et al.,
1999), and therefore we focused on the characterization of
golgin-45. The only obvious sequence feature of golgin-45
was a predicted coiled-coil region (Fig. 1 A) reminiscent of
GM130 and the golgin family of coiled-coil proteins (Fritz-
ler et al., 1993; Nakamura et al., 1995). Golgin-45 binds
to GRASP55 via a COOH-terminal sequence, since dele-
tion of its last seven amino acids abolishes the interaction
(Fig. 1 A), similar to the binding of GM130 to GRASP65.
GRASP65 also showed an interaction with golgin-45 in the
two-hybrid system (Fig. 1 A). These results were confirmed
by immunoprecipitation of in vitro–translated GRASP pro-
teins, golgin-45, and GM130 (Fig. 1 B). Golgin-45 bound
more GRASP55 than GRASP65 in vitro, whereas the con-
verse was true for GM130 (Fig. 1 B). The second part of
our approach was to purify endogenous GRASP55 com-
plexes from detergent extracts of Golgi membranes (Fig. 1
C). Analysis of the interacting proteins by mass spectrom-
etry revealed that the major protein of 55 kD was
GRASP55, and a doublet of 45–50 kD was the rat ho-
mologue of golgin-45 (Fig. 1 C). These results confirm
the two-hybrid data and demonstrate that endogenous
GRASP55 and golgin-45 are present in the same complex.
We next asked if golgin-45 is a GRASP55-specific binding
protein in vivo. For this purpose, antibodies were raised
against golgin-45; these recognize a protein of the expected
size in Golgi membranes competed by the addition of the
recombinant antigen (Fig. 1 D). Western blot analysis of
GRASP55, GRASP65, golgin-45, and GM130 immuno-
precipitates showed that golgin-45 is only found in a com-
plex with GRASP55, whereas GRASP65 is only found to-
gether with GM130 and not golgin-45 (Fig. 1 E). Some
GM130 was found in GRASP55 immunoprecipitates, but
since the amount of GRASP55 was below the level of detec-
tion in the reciprocal immunoprecipitation with GM130
we conclude this is not the major GRASP55 complex in
Golgi membranes. These data suggest that GRASP55 and
GRASP65 form specific complexes in vivo with golgin-45
and GM130, respectively.
Figure 1. Golgin-45 is a novel GRASP55 interacting protein. (A) Amino acids 12–404 of golgin-45 were identified using the yeast two-
hybrid system by screening GRASP55 against a human testis cDNA library. Golgin-45 and a COOH-terminal deletion mutant were tested for 
interaction with GRASP55 and GRASP65 in the yeast two-hybrid system compared with GM130 and empty vector as positive and negative 
controls, respectively. (B) Coimmunoprecipitations of in vitro–translated GRASP55 and GRASP65 with golgin-45 and GM130. (C) GRASP55 
complexes were affinity purified from detergent extracts of Golgi membranes. Specifically, interacting proteins were excised (arrowheads) 
and tryptic digests of the proteins contained therein analyzed by mass spectrometry. (D) Golgi membranes (10  g) were Western blotted with 
antibodies to golgin-45 in the presence ( ) or absence ( ) of 10  g/ml of recombinant golgin-45. Control blots are also shown for the anti-
bodies to GRASP65, GRASP55, and GM130. (E) Immunoprecipitations (IPs) were performed from 20  g Golgi membranes with the following 
antibodies: sheep anti-GRASP55, mouse anti-GRASP65, sheep anti-GM130, and rabbit anti–golgin-45. Immunoprecipitates were blotted 
with the following antibodies: GRASP55 and GRASP65 IPs with rabbit anti-GM130 and rabbit anti–golgin-45, GM130 IPs with rabbit anti-
GRASP55 and mouse anti-GRASP65, and golgin-45 IPs with sheep anti-GRASP55 and mouse anti-GRASP65. Asterisks indicate a nonspecific 
cross-reactivity of the rabbit anti-GRASP55 antibody to the sheep antibody used for the IP. 
Golgin-45, a novel rab2 effector |
 
 Short et al. 879
 
Several Golgi-associated coiled-coil proteins have been
shown to interact with the activated or GTP forms of the rab
family of GTPases involved in membrane traffic. In particu-
lar, both p115 and GM130 bind to the GTP form of the
small GTPase rab1 (Allan et al., 2000; Moyer et al., 2001;
Weide et al., 2001). Since golgin-45 shares several properties
with GM130, we tested if it interacted with Golgi-localized
rab GTPases. Golgin-45 from Golgi membranes bound
quantitatively and specifically to the GTP form of rab2 and
showed negligible binding to other inactive or activated rabs
(Fig. 2 A). GRASP55 was also specifically eluted from rab2-
GTP beads consistent with its interaction with golgin-45. In-
triguingly both GM130 and p115 bound to both activated
rab1 and rab2 but not the inactive forms of these rabs or any
form of rab6 (Fig. 2 A). The yeast two-hybrid system was
then used to screen for interactions between golgin-45,
GM130, or p115 and the Golgi rabs 1, 2, and 6 with endoso-
mal rab5 as a negative control. Golgin-45 interacted strongly
with the rab2 activated mutant but only weakly with wild-
type rab2 (Fig. 2 B). None of the other rab proteins tested
showed an interaction with golgin-45. The ability to detect
the known interactions between an activated form of rab1
and p115 or GM130 (Fig. 2 B) demonstrates the validity of
this approach for studying specific rab-effector protein inter-
actions. GM130 was also able to interact strongly with the
activated mutant of rab2 and much less with the wild-type
protein (Fig. 2 B), confirming the results of the rab2 binding
assays from Golgi membranes. These findings are consistent
with direct interaction between the active form of rab2 and
golgin-45, rab1 and p115, rab 1 or rab2, and GM130. The
presence of p115 in rab2-GTP binding assays is probably due
to its binding to GM130, since it interacts with rab1 but not
with rab2 in the two-hybrid system. The rab2-binding site in
golgin-45 lies in the predicted coiled-coil domain, demon-
strating the functional significance of the weak homology to
other golgins in this region (Fig. 2 C).
Figure 2. Golgin-45 is a specific binding partner for activated 
rab2, whereas GM130 binds both rab1 and 2. (A) Rab1, 2, and 6 
beads loaded with either GDP or GTP S were incubated with Golgi 
extract and the specifically eluted proteins analyzed by Western 
blotting. Note that golgin-45 is depleted from the supernatant of 
rab2-GTP beads. (B) Full-length golgin-45 and p115 were tested for 
interaction with wild-type rab2 and the following rab proteins
carrying activating point mutations rab1Q70L, rab2Q65L, 
rab5Q79L, and rab6Q72L. (C) Full-length and truncation mutants of 
golgin-45 were tested for interaction with rab2Q65L and GRASP55 
in the yeast two-hybrid system. Interaction was scored by assessing 
growth on QDO plates, from none ( ) to strong (   ).
Figure 3. Golgin-45 behaves like a Golgi matrix protein upon BFA 
treatment. (A) Normal rat kidney (NRK) cells were fixed and then 
stained with antibodies to golgin-45 and GRASP55. In the merged 
images, DNA is blue, golgin-45 is indicated in red, GRASP55 in 
green, with yellow indicating areas of golgin-45 and GRASP55 
overlap. (B) NRK cells were treated with 5  g/ml BFA or 200 ng/ml 
nocodazole for 30 and 60 min, respectively, before fixation and
antibody staining. (C) NRK cells were transfected with GFP–golgin-45 
for 12 h and then fixed and stained with antibodies to GRASP55. 
Bar, 10  m. 
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Golgin-45 was localized to the Golgi apparatus using im-
munofluorescence microscopy (Fig. 3 A). Comparison of
GRASP55 and golgin-45 staining revealed extensive colo-
calization consistent with these proteins existing in a com-
plex on Golgi membranes (Fig. 3 A). Treatment of cells
with the drug brefeldin A (BFA)* causes Golgi enzymes to
redistribute back to the ER, whereas Golgi matrix proteins
remain in Golgi remnants (Seemann et al., 2000a). As ex-
pected for a Golgi matrix protein, BFA treatment caused
golgin-45 staining to become vesiculated and dispersed
throughout the cell to Golgi remnants rather than redistri-
bution to the ER (Fig. 3 B). Similarly, the microtubule de-
polymerizing drug nocodazole, known to disrupt the Golgi
apparatus into smaller “mini-stacks” (Rogalski et al., 1984),
caused golgin-45 staining to become dispersed (Fig. 3 B).
Overexpression of full-length golgin-45 resulted in a dis-
ruption of the Golgi similar to the structures observed with
nocodazole treatment (Fig. 3 C). Therefore, Golgin-45 dis-
plays the behavior of a Golgi matrix protein rather than a
Golgi enzyme or vesicle coat protein and may be important
for Golgi structure.
To investigate the requirement for golgin-45 in maintain-
ing normal Golgi structure, we used RNA interference with
21 base RNA duplexes (Elbashir et al., 2001). Duplexes tar-
geting golgin-45 but not a control protein lamin-A (unpub-
lished data) were able to deplete golgin-45 to an undetect-
able level. This resulted in the redistribution of the Golgi
enzyme 
 
n
 
-acetylglucosaminyltransferase-I to give a nuclear
envelope plus reticular ER-like staining (Fig. 4 A), whereas
GRASP55 (Fig. 4 B) and GM130 (Fig. 4 C) were found in
small punctate structures with some diffuse cytosolic and re-
ticular staining. Therefore, depletion of golgin-45 disrupts
the Golgi apparatus as defined by components of the cis-
and medial-cisternae and a resident medial-Golgi enzyme.
We then examined whether or not golgin-45 is required
for secretory protein transport in light of its rab2-binding
properties. A biochemical assay relying on protein glycosyla-
tion was not used due to the redistribution of Golgi enzymes
to the ER in golgin-45–depleted cells (Fig. 4 A), something
that would complicate the analysis. Therefore, we made use
of a GFP-tagged temperature-sensitive allele of the vesicular
stomatitis virus G protein (VSV-G ts045), a well-character-
ized secretory marker used previously to demonstrate the
role of GM130 and other factors in protein transport with
microscopy-based assays (Pepperkok et al., 1993; Scales et
al., 1997; Seemann et al., 2000b). At the nonpermissive
temperature of 39.5
 
 
 
C, VSV-G accumulated in the endo-
plasmic reticulum of both control (Fig. 5 A) and golgin-45–
depleted cells (Fig. 5 B). After chase periods of 30 or 60 min
at 31.5
 
 
 
C, VSV-G was transported efficiently via the Golgi
apparatus to the cell surface in control (Fig. 5 A) but not in
golgin-45–depleted cells (Fig. 5 B). Quantitation of this ef-
fect revealed an almost complete block in transport of VSV-
G after golgin-45 depletion (Fig. 5 C). Live cell imaging
confirmed these observations and revealed that VSV-G
ts045 is trapped in the ER when the Golgi apparatus is dis-
rupted by golgin-45 depletion (see videos 1 and 2 avail-
able at http://www.jcb.org/cgi/content/full/jcb.200108079/
DC1). Therefore, Golgin-45 is not only required for normal
Golgi structure but also for protein transport from the ER
through the Golgi apparatus to the cell surface.
Figure 4. Depletion of golgin-45 disrupts the Golgi apparatus. (A) 
HeLa cells were treated with duplex RNA to target golgin-45 for 36 h 
and then transfected for a further 18 h with a plasmid encoding 
GFP-tagged n-acetylglucosaminyltransferase-I before fixation and 
staining with antibodies to golgin-45. (B and C) HeLa cells were 
treated with RNA duplexes to target golgin-45 for 48 h before
fixation and staining with antibodies to golgin-45, GRASP55, and 
GM130. Bars, 10  m.
 
*Abbreviations used in this paper: BFA, brefeldin A; ER, endoplasmic
reticulum; GFP, green fluorescent protein; IP, immunoprecipitation;
VSV-G, vesicular stomatitis virus G protein. 
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To maintain normal secretion and Golgi function, there
must be a balance of membrane traffic to and from the
Golgi apparatus; otherwise it would either be consumed or
grow uncontrollably (Warren and Malhotra, 1998). Golgi
matrix proteins together with rab GTPases are positioned
perfectly to control both Golgi structure and membrane
traffic, thereby balancing the surface area available for mem-
brane fusion with that sequestered in the stacked cisternal
core of the Golgi apparatus. Our observations that the
GRASP55- and GRASP65-golgin complexes interact with
multiple rab GTPases help to explain why nonhydrolyzable
GTP analogs promote the stacking of Golgi cisternae in
vitro (Rabouille et al., 1995) and support the hypothesis that
stacking is a form of membrane tethering (Barr et al., 1997;
Shorter and Warren, 1999; Waters and Pfeffer, 1999). The
cis to trans polarity of the Golgi stack may therefore be es-
tablished by the sequential action of different GRASP-gol-
gin vesicle docking complexes together with the rab
GTPases. These results also question the idea that vesicle
transport does not occur between Golgi cisternae and that
cisternal maturation is the only anterograde transport mech-
anism (Bonfanti et al., 1998). Rab2 has been implicated pre-
viously in anterograde vesicular transport (Tisdale et al.,
1992), and we show that the rab2 effector protein golgin-45
is in a complex with the medial-Golgi protein GRASP55,
indicating that vesicle transport to this Golgi subcompart-
ment is likely to occur.
 
Materials and methods
 
Purification of GRASP55 complexes
 
GRASP55 affinity matrix was made by covalently coupling 1 mg purified
antibody to 1 ml of protein G–sepharose (Amersham-Pharmacia Biotech)
using dimethylpimelidate (Harlow and Lane, 1998). Purified Golgi mem-
branes (Hui et al., 1998) were extracted for 15 min on ice at a concentra-
tion of 1 mg/ml in HNT buffer (50 mM Hepes-KOH, pH 7.2, 200 mM
NaCl, and 0.5% Triton X-100) containing protease inhibitors (Mini EDTA-
free; Roche Diagnostics). Insoluble material was removed by centrifuga-
tion at 20,000 
 
g
 
 for 20 min at 4
 
 
 
C. GRASP55 complexes were isolated by
incubating 4 mg Golgi membrane extract with 100 
 
 
 
l of the GRASP55 af-
finity matrix for 2 h at 4
 
 
 
C. After four washes with 500 
 
 
 
l HNT, bound pro-
teins were eluted in 100 
 
 
 
l of 3% SDS then precipitated with 12% (wt/vol)
trichloracetic acid.
 
Mass spectrometry
 
Proteins were extracted from Coomassie blue–stained gel slices and di-
gested with sequencing-grade porcine trypsin (Promega) for analysis by
peptide mass fingerprinting using a MALDI-TOF instrument (Reflex III;
Bruker) and probability-based database searching (Perkins et al., 1999).
 
Rab-effector binding assays
 
Recombinant rab proteins (0.5 mg) bound to 50 
 
 
 
l glutathione-sepharose
(Amersham Pharmacia Biotech) were loaded with either GDP or GTP
 
 
 
S
(Christoforidis and Zerial, 2000). These beads were incubated in the pres-
ence of 10 
 
 
 
M GDP or GTP
 
 
 
S and 200 
 
 
 
g Golgi extract in HNTM (HNT
containing 5 mM MgCl
 
2
 
) in a total volume of 400 
 
 
 
l for 1 h on ice. Beads
were washed three times with 500 
 
 
 
l HNTM containing 10 
 
 
 
M GDP or
GTP
 
 
 
S, and then bound proteins were eluted with HNT containing 20 mM
EDTA, precipitated with 12% (wt/vol) trichloracetic acid, and analyzed by
Western blotting.
 
Molecular biology and two-hybrid screening
 
Standard molecular biology techniques were used for all constructs;
primer sequences are available upon request. The rat GRASP55 cDNA was
inserted into the EcoRI and SalI sites of the two-hybrid bait vector pGBT9,
and this plasmid transformed into the reporter strain PJ69-4A according to
Figure 5. Depletion of golgin-45 disrupts transport of VSV-G 
protein from the ER to the cell surface. Control (A) or golgin-45 
(B) RNAi cells were transfected with a plasmid encoding GFP-tagged 
VSV-G ts045 protein. VSV-G ts045was arrested in the ER at 
39.5 C and then chased out at 31.5 C for 30 and 60 min. Images 
are shown of cells fixed after 0, 30, and 60 min of chase for both 
total and cell surface–associated VSV-G. (C) The extent of VSV-G 
transport after 0, 30, and 60 min chase at 31.5 C was measured 
in control and golgin-45–depleted cells. This ratio does not approach 
unity due to the different dyes used to measure surface and total 
fluorescence. The data shown is representative of three
experiments with n   20 for all data points in each experiment. 
Live cell videos showing VSV-G ts045 transport in control and 
golgin-45 depleted cells are available at http://www.jcb.org/cgi/
content/full/jcb.200108079/DC1. Bars, 20  m. 
882 The Journal of Cell Biology 
 
|
 
 
 
Volume 155, Number 6, 2001
 
the CLONTECH Laboratories yeast protocol handbook. A human testis
cDNA library was transformed into this bait strain and plated on synthetic
media lacking leucine, tryptophan, histidine, and adenine with 2% glu-
cose as the carbon source (QDO). Library plasmids were rescued and re-
transformed into PJ69-4A together with either pGBT9 or the GRASP55 bait
plasmid on synthetic medium lacking leucine and tryptophan (
 
 
 
LW) and
then restreaked onto QDO. Those showing strong growth on QDO after
2 d at 30
 
 
 
C were taken as positive clones and the inserts sequenced. Light
colored streaks indicate strong interaction, whereas dark colored streaks
indicate weak or no interaction. Golgin-45 (sequence data available from
GenBank/EMBL/DDBJ under accession no. AK006544) was amplified from
mouse liver and rab proteins from human cDNA for cloning into vectors
for bacterial and mammalian expression. Mutagenesis was performed us-
ing the Quickchange protocol (Stratagene), and constructs were confirmed
by DNA sequencing (Medigenomix).
 
Cell culture and RNA interference
 
NRK and HeLa cells were cultured at 37
 
 
 
C and 5% CO
 
2
 
 in DME contain-
ing 10% calf serum (Life Technologies). RNA interference was performed
on HeLa cells transfected using oligofectamine (Life Technologies) with
duplex RNA (Dharmacon Research, Inc.) for 24 h; coverslips were then
placed in fresh growth medium for a further 48 h and processed for fluo-
rescence microscopy (Elbashir et al., 2001). Golgin-45 was targeted with
the sequence AATCCGAGGAGCAGGAGATGGAA, and the lamin-A con-
trol was described previously (Elbashir et al., 2001). Images were collected
using a ZEISS Axioskop-2 with 63
 
 
 
 Plan Apochromat oil immersion ob-
jective with a 1.4 NA, a 1,300 by 1,030 pixel cooled CCD camera (Prince-
ton Instruments), and Metaview software (Universal Imaging Corp.).
 
VSV-G protein transport assays
 
VSV-G ts045 protein transport assays were performed using an adaptation
of a published protocol (Seemann et al., 2000b). HeLa cells plated on glass
coverslips were treated with golgin-45 or lamin-A–specific RNA duplexes
for 36 h at 37
 
 
 
C and then transfected with a plasmid encoding green fluo-
rescent protein (GFP)–tagged VSV-G protein for 2 h at 37
 
 
 
C then 12 h at
39.5
 
 
 
C (Toomre et al., 1999). The cells were then incubated at 4
 
 
 
C to pro-
mote VSV-G protein folding (Scales et al., 1997), and afterwards the
growth medium was replaced with prewarmed medium at 31.5
 
 
 
C. After
the required chase period, cells were fixed with 3% paraformaldehyde in
PBS. Cell surface VSV-G was detected with a monoclonal antibody to the
VSV-G lumenal domain and a donkey anti–mouse secondary coupled to
CY3 (Jackson ImmunoResearch Laboratories) and total VSV-G by GFP
fluorescence. The ratio of surface to total measured fluorescence was used
to calculate the extent of VSV-G protein transport (Seemann et al., 2000b).
 
Online supplemental material
 
Videos 1 and 2 (available at http://www.jcb.org/cgi/content/full/
jcb.200108079/DC1) are supplemental materials for Fig. 5. Cells were pre-
pared for live cell imaging of VSV-G transport essentially identically to the
fixed cell procedure except that cells were plated in Labtek coverglass
chamber slides (Nunc), and the chase was performed in CO
 
2
 
-independent
medium with 10% calf serum. A ZEISS Axiovert-2 with Plan Neofluar 63
 
 
 
oil immersion objective (1.3 NA), a heated sample stage, and a Till Photo-
nics imaging system were used to collect and process data. Prior to imag-
ing, the media was overlaid with mineral oil (Sigma-Aldrich) to prevent
evaporation. GFP fluorescence was imaged every 30 s with 100 ms expo-
sure time using excitation at 470 nm from a monochromator. Five focal
planes spaced by 100 
 
 
 
m were captured to enable visualization of the ER,
Golgi, and cell surface.
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